Event details
Date
Time
Duration
Available On-Demand
The use of natriuretic peptide testing in clinical practice provides information that may not be obvious at the patient’s bedside. This online seminar discusses the latest clinical application of natriuretic peptides, examining how testing may support clinical judgment, reduce cost, and decrease serious medical events. In addition, this seminar will include an exploration of the relationship between natriuretic peptide levels and guideline-directed medical therapy in the inpatient and outpatient settings.
Key Learning Objectives:
- Review the use of natriuretic peptide testing in the diagnosis and determination of disease severity in heart failure
- Identify the latest trends for use of natriuretic peptide testing in today’s clinical practice
- Examine the potential use of natriuretic peptides in relation to guideline-directed medical therapy
Who should attend?
Physicians, nurses, physician assistants, nurse practitioners, laboratorians, pathologists, biologists and medical technologists.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Accreditation statement
SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of this one-hour webinar are also entitled to 1.0 ACCENT Continuing Education Credits from the AACC. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@aacc.org.
Presenter
Dr. James Januzzi, M.D., is the Hutter Family Professor of Medicine at Harvard Medical School, and a Cardiologist at Massachusetts General Hospital and Senior Cardiometabolic Faculty at Baim Institute for Clinical Research. His research has contributed to the understanding of cardiac biomarker testing and has played a role in setting international standards used in the diagnosis, prognosis and management of heart failure patients.
Ellie studied biochemistry at the University of Nottingham, UK, and has previous experience working in management consultancy. As a member of the Editorial team, she now plays an integral role in shaping the content on SelectScience.